Ritonavir Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / COVID-19 Pneumonia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04261270A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia